1. Introduction {#sec1}
===============

Coenzyme Q10 (CoQ10), also known as ubiquinone or ubiquinone-10, occurs widely in animals, plants, and the cells of microorganisms. It plays a crucial role in generation of cellular energy and in free radical scavenging in the human body \[[@B1]\]. Accordingly, it has been used in therapeutic applications for several diseases such as heart disease \[[@B2]\], breast cancer \[[@B3]\], and Alzheimer\'s and Parkinson\'s diseases \[[@B4]\]. Moreover, CoQ10 has been used as a food supplement and cosmetic ingredient because of its various physiological functions. Extensive attempts have been made to increase CoQ10 production to meet growing demands for this product. To date, production of CoQ10 is produced by one of three methods: extraction from biological tissues \[[@B5]\], chemical synthesis \[[@B6]\], and microbial fermentation \[[@B7]\]. In the wake of recent environmental awareness, the first two methods became least desirable because of the inherent uses of solvents and chemicals in the process. Microbial fermentation, conversely, offers an environmentally benign option based on the enzymatic catalysis at the cellular level for CoQ10 assembly. Also, this approach is attractive to the industry because the process is easy to control and has a relatively low production cost \[[@B8], [@B9]\]. Among all strains investigated so far, *A. tumefaciens* has been shown to be an excellent producer of CoQ10 \[[@B7], [@B10]--[@B13]\]. However, the yield of CoQ10 in liquid cultivation using the wild-type strain of *A. tumefaciens* remains limited because of its low specific CoQ10 content.

To increase the specific CoQ10 content of *A. tumefaciens*, further strain development by physical and chemical mutagenesis has been used to obtain high-CoQ10-producing mutants. Well-known mutagens such as ultraviolet radiation and diethyl sulfate (DES) have been tested. However, the chemicals used for these mutagenesis procedures are harmful to human health. It is desirable to find new mutagenic treatments to increase CoQ10 yield.

In recent years, there were reports about high hydrostatic pressure (HHP) treatment that influenced the structure of genes and proteins in microorganisms \[[@B14]--[@B16]\]. There were also reports that HHP treatment in laboratory could cause beneficial mutagenesis to *E. coli* \[[@B17], [@B18]\], *R. glutinis* \[[@B19], [@B20]\], and *G. xylinus* \[[@B21]\]. Compared with traditional physical and chemical mutagenesis methods, HHP treatment as a mutagen could offer some advantages such as easier handling, savings in time and money, and negligible effects to the environment \[[@B19], [@B20]\]. However, little is known related to the effectiveness of HHP treatment on improving the production of CoQ10 in microorganisms.

Carbon and nitrogen sources significantly affected cell growth and CoQ10 production \[[@B12]\]. Aside from the optimization of carbon and nitrogen sources, the use of fed-batch culture by controlling the nutrient feeding is one of the most popular methods to achieve high cell density of *E. coli* \[[@B22]--[@B24]\] and enhance the production of CoQ10 \[[@B11], [@B12]\]. Exponential feeding is a simple method that was widely employed for *E. coli* cultivation \[[@B23]\]. So far, there seem to be no published reports related to the CoQ10 production under exponential feeding fed-batch control.

In this study, HHP treatment was investigated as a new mutagenic treatment to increase the specific CoQ10 content of *A. tumefaciens*. A mutant strain PK38 was isolated using selection markers and the optimal carbon and nitrogen sources for CoQ10 production with PK38 were selected. A new exponential feeding strategy was proposed for improving CoQ10 production using PK38.

2. Materials and Methods {#sec2}
========================

2.1. Microorganism and Culture Medium {#sec2.1}
-------------------------------------

The parental strain *A. tumefaciens*1.2554 was purchased from China General Microbiological Culture Collection Center (CGMCC, Beijing, China). This strain was inoculated on mannitol agar slants, incubated for 2 days at 28°C, and then stored at 4°C.

All media were sterilized by autoclaving at 121°C for 20 min and were adjusted to pH 7.2 before sterilization. The complete medium contained 5 g/L glucose, 3 g/L beef extract, 3 g/L yeast extract, 10 g/L peptone, and 0.2 g/L MgSO~4~·7H~2~O. The selective medium was made by adding a certain amount of one of the following four substances: sodium azide, ethionine, daunomycin, or vitamin K~3~. The seed medium consisted of 10 g/L glucose, 5 g/L peptone, 5 g/L yeast extract, and 5 g/L NaCl. The basal fermentation medium contained 20 g/L glucose, 10 g/L peptone, 10 g/L yeast extract, 0.5 g/L K~2~HPO~4~, 0.5 g/L KH~2~PO~4~ 0.5 g/L, and 0.5 g/L MgSO~4~·7H~2~O.

2.2. Preparation of Cell Suspensions {#sec2.2}
------------------------------------

One loop of bacterial cells grown overnight on a mannitol agar slant was inoculated to 250 mL Erlenmeyer flask containing 50 mL of a seed medium and incubated on a rotary shaker (200 rpm) at 28°C for 24 h. After the culture entered the log phase (about 18--24 h in this study), 20 mL culture broth was centrifuged under 4°C at 10,000 rpm (21,000 ×g) for 10 min (PM180R, ALC International, Milan, Italy), washed twice with sterile physiological saline, and suspended in sterile 0.1 M potassium phosphate buffer of pH 7.2 (cells density 10^6^--10^7^ cell/mL) for HHP treatment.

2.3. HHP Mutation {#sec2.3}
-----------------

The cell suspension in potassium phosphate buffer was transferred aseptically into sterile polyethylene pouches and heat-sealed following the expulsion of air. The prepared pouches were placed into the HHP equipment, containing a 2 l working pressure chamber (UHPF-750MP, Baotou Kefa New Type Hi-Tech Food Machine Limited Company, Baotou, China). HHP treatments at constant pressures from 100 to 400 MPa with holding time (10 to 30 min) were carried out at room temperature (about 25°C) using castor oil as the pressure medium. Control samples were maintained at atmospheric pressure within the constant temperature housing during the experiment.

To assess loss of viability caused by the HHP treatment, untreated and treated cell suspensions were serially diluted in PBS and plated on the basal agar plates. Agar plates were incubated at 28°C for 2 days for colony counting. Inactivation was expressed as a logarithmic viability reduction log⁡⁡(*N*~0~/*N*), with *N*~0~ and *N* representing the colony counts before and after treatment, respectively \[[@B25]\].

2.4. UV + DES Mutation {#sec2.4}
----------------------

The cell suspension was spread onto a presterilized plate (9 cm diameter), and a UV lamp (254 nm, 30 W) was used for the mutation by irradiating cells at a distance of 30 cm from the plate for 60 s. After UV radiation treatment, the cell suspension was treated with 1% (v/v) DES for 20 min. The results show that the frequency of positive mutant generation is 12%.

2.5. Screening for High-CoQ10-Producing Mutant {#sec2.5}
----------------------------------------------

After each treatment, cell suspensions were spread on the selective medium and incubated at 28°C for 48 h. The selective medium contained L-ethionine (500 mg/L), daunomycin (20 mg/L), vitamin K~3~ (160 mg/L), or sodium azide (20 mg/L). All these chemicals were purchased from Ding Guo Biological Technology Co., LTD (Beijing, China). The fast-growing, large, and single colony was transferred onto the selective medium plate and then incubated for 48 h at 28°C. The slant was preserved at 4°C.

For screening, each mutant was taken and used in fermentation, and the content of CoQ10 from each mutant was determined.

2.6. Fermentation {#sec2.6}
-----------------

The seed culture was transferred into a stirred tank fermentor (BioFlo 110, New Brunswick, NJ, USA) with a working volume of 2 l production medium. The temperature, agitation speed, and air flow rate during the culture were 28°C, 300 rpm, and 0.6 l/min, respectively. The pH was controlled at 7.2 ± 0.1 by addition of 3 M NaOH or 2 M HCl.

2.7. Analytical Methods {#sec2.7}
-----------------------

The cell mass concentration was determined using a calibration curve constructed by optical density at 620 nm and dry cell weight (DCW). The optical density at 620 nm was measured with a spectrophotometer (UV-2500, Shimadzu, Tokyo, Japan). The DCW was determined after the culture broth was centrifuged at 10,000 rpm (21,000 ×g) for 10 min under 4°C using an ultracentrifuge. Cell lysis and CoQ10 extraction conducted in this study were similar to that described by Tian et al. \[[@B26]\]. The extracted CoQ10 was dissolved in ethanol and applied to a high-performance liquid chromatography (HPLC) system (LC-2010A, Shimadzu, Tokyo, Japan) with a Hypersil ODS C18 (5 *μ*m, 4.6 mm × 250 mm, Germany) coupled with a UV detector (Waters 486). The column was eluted with ethanol and methanol (9 : 1, v/v) at a flow rate of 1.0 mL/min, and a chromatogram was obtained by monitoring the absorbance at 275 nm. With an authentic CoQ10 standard (Sigma Co., Shanghai, China), CoQ10 was identified according to retention time and quantified by using a calibration curve. The residual sugar was quantified by Fehiling\'s reaction.

2.8. Statistical Analysis {#sec2.8}
-------------------------

All analyses were performed in triplicate. The experimental results obtained were expressed as means ± SD. Statistical analysis was performed using the SPSS package (version 11.5, SPSS Inc., Chicago, IL). Data were analyzed by analysis of variance (*P* \< 0.05), and the means were separated by Duncan\'s multiple range test.

3. Results and Discussion {#sec3}
=========================

3.1. Effect of HHP Treatment on Lethal Rate and Mutation of *A. tumefaciens* {#sec3.1}
----------------------------------------------------------------------------

To determine the optimum mutagenic conditions by HHP treatment, cell suspensions of *A. tumefaciens* were subjected to different HHP treatments combining pressure with holding time at 25°C. [Figure 1](#fig1){ref-type="fig"} shows the death curve of *A. tumefaciens* with HHP treatment. The data revealed that HHP treatment had a significant effect on *A. tumefaciens*, a Gram-negative bacterium. In general, Gram-negative bacteria are less resistant than the Gram-positive bacteria to HHP treatments \[[@B25]\]. In this study, the cell viability during HHP treatment decreased with the increase of processing pressure and holding time. Based on the curve ([Figure 1](#fig1){ref-type="fig"}), deactivation of cells occurred between 4.0 and 4.5 log units at 200 MPa for 30 min, 250 MPa for 20 min, or 400 MPa for 10 min. Under these three levels, the mortality of *A. tumefaciens* was close to 100% (data not shown). Therefore, these three levels were chosen for subsequent mutagenesis \[[@B21]\].

[Table 1](#tab1){ref-type="table"} shows the effect of HHP treatments on mutation of *A. tumefaciens*. It is evident that the HHP treatment, at 200 MPa for 30 min, is better than the other two treatments: 250 MPa for 20 min and 400 MPa for 10 min. Positive mutations accounted for 16% of these mutants, and 12 strains had a specific CoQ10 content higher than that from the wild-type strain. Among those 12 strains, maximum specific CoQ10 content was achieved from the mutant PN07 with an approximate 17.5% increase compared with the wild-type strain. So the HHP treatment at 200 MPa for 30 min was selected as the optimal condition for inducing mutation.

CoQ10 biosynthesis is typically composed of three parts: synthesis of a quinonoid ring, synthesis of decaprenyl diphosphate, and quinonoid ring modification \[[@B9]\]. The formation of each part is catalyzed by several enzymes. For example, decaprenyl diphosphate synthase (DPPS) can catalyze the synthesis of decaprenyl diphosphate, which appears to be a rate-limiting step and critical in CoQ10 production \[[@B9], [@B27]\]. The present study found that HHP treatment can have beneficial mutagenic effects on *A. tumefaciens* for CoQ10 production, which agrees with the finding of Wu et al. \[[@B21]\] who found that the bacterial cellulose mutant M~438~ was obtained after HHP treatment at 250 MPa for 15 min. Wang et al. \[[@B19], [@B20]\] obtained the barotolerant mutant PR68 after five repeated cycles of HHP treatment at 300 MPa for 12 min. They found that the DNA segments of mutant PR68 were different from the original strain. Lauro et al. \[[@B28]\] reported that pressure triggered a stress response which activated distinct chaperones and DNA repair proteins. So the change of specific CoQ10 content of *A. tumefaciens* might occur at the gene level, and HHP treatment might have effects on the three enzymatic steps of CoQ10 biosynthesis. Study of these effects should be carried out in future research.

3.2. Screening **A. tumefaciens** {#sec3.2}
---------------------------------

Random mutagenesis is an easy tool to use in achieving genetic and functional modifications of an organism. Using progressive stepwise mutagenesis-selection protocols and various mutagens with differing modes of action has been proven effective in increasing product yield \[[@B29]\]. To obtain a high-CoQ10-producing strain from the wild type, mutagenesis was carried out by the HHP treatment (200 MPa, 30 min) and UV+DES mutation. After each mutagenic treatment, the mutant strain was selected and assessed in shake flask cultures. The most promising strain was subjected to the next mutagenic treatment.

According to the general pathway of CoQ10 synthesis, two means of additional CoQ10 production are possible: the mutant could overcome growth inhibition during CoQ10 biosynthesis or its related metabolisms might overproduce CoQ10 \[[@B9]\]. These chemicals included L-ethionine (an analogue of L-methionine, which is a precursor for the methoxy moiety of CoQ10), daunomycin, and vitamin K~3~ (structural analogs of CoQ10). CoQ10 is an electron carrier in the respiration chain with antioxidant activity \[[@B30]\]. An electron flux inhibitor, such as sodium azide, can be used for screening the mutant, which can be resistant to this inhibitor because of high intracellular CoQ10 \[[@B9]\]. Moreover, tyrosine is located at a final branch point in the pathway of CoQ10 biosynthesis. So a tyrosine auxotrophic mutant might enhance CoQ10 production.

As [Figure 2](#fig2){ref-type="fig"} shows, the mutant strains isolated with respective chemicals at each mutation step were tested for their CoQ10 production by flask culturing, and the best strain was used as the parent for successive mutations. [Figure 2](#fig2){ref-type="fig"} also shows the methods and the maximal specific CoQ10 content for such mutants. Among those chemicals used for selecting a high producer, daunomycin had no significant effect on the CoQ10 content. Finally, the strain with the highest specific CoQ10 content, named PK38, was obtained, containing about 52.83% higher specific CoQ10 content when compared with the original strain.

3.3. Stability of PK38 for CoQ10 Production {#sec3.3}
-------------------------------------------

The mutant PK38 was selected, and its stability of producing specific CoQ10 content was investigated ([Table 2](#tab2){ref-type="table"}). There was little fluctuation in specific CoQ10 content among 10 generations. Also, the genetic markers were stable. This illustrated PK38 strain has a good genetic stability and has the potential to be used for CoQ10 production.

3.4. Optimization of Carbon and Nitrogen Sources {#sec3.4}
------------------------------------------------

To determine the optimal carbon and nitrogen source for CoQ10 production, cultures were prepared in 250 mL flasks containing 100 mL of fermentation medium with various carbon and nitrogen sources and incubated for 72 h on a rotary shaker (at 180 rpm) at 28°C.

[Figure 3](#fig3){ref-type="fig"} shows the effect of different carbon sources on PK38 growth and CoQ10 production. Among the various carbon sources (glucose, fructose, lactose, maltose, sucrose, and xylose), sucrose proved to be the best carbon source for the growth of PK38 with biomass reaching 5.28 g/L after 72 hours of cultivation. Also, CoQ10 production was the highest when sucrose was used as a carbon source, reaching 12.27 mg/L. These results are in agreement with the work conducted by Ha et al. \[[@B12]\]. To evaluate the effect of the initial concentrations of sucrose on PK38 growth and CoQ10 production, different concentrations of sucrose (10, 20, 30, 40, and 50 g/L) were used. As [Table 3](#tab3){ref-type="table"} shows, CoQ10 production was highest at 30 g/L of sucrose, reaching 14.88 mg/L. So sucrose, at a concentration of 30 g/L, was selected as carbon source for CoQ10 production with PK38.

[Figure 4](#fig4){ref-type="fig"} shows the effects of different nitrogen sources on biomass and CoQ10. The results demonstrate that crop steep powder (CSP) was more desirable than other nitrogen sources. The highest CoQ10 production (17.65 mg/L) was obtained with 20 g/L of CSP, with the highest biomass at 7.16 g/L. CSP comprises the water soluble components of the crop, the composition of which is primarily amino acids, peptides, carbohydrates, and salts. CSPs are rich in nitrogen, vitamins, and other growth stimulating compounds. Therefore, CSP was used as an ingredient in media for cultivation of microorganisms. Different concentrations of CSP (10, 20, 30, 40, and 50 g/L) were used to evaluate the effect of the initial concentrations of CSP on PK38 growth and CoQ10 production. As [Table 4](#tab4){ref-type="table"} shows, CoQ10 production was the highest with 30 g/L of sucrose, reaching 18.92 mg/L. Ammonium may also have effects on CoQ10 synthesis. Knowles and Redfearn \[[@B31]\] found that the cells of *Azotobacter vinelandii*grown on ammonium medium produced comparatively high concentrations of CoQ10. Obviously, the complex nitrogen source (CSP + ammonium sulfate) was more desirable than single nitrogen sources ([Table 5](#tab5){ref-type="table"}). CoQ10 production reached 20.62 mg/L with 30 g/L CSP and 10 g/L ammonium sulfate in the production medium.

3.5. Fed-Batch CoQ10 Fermentation in 5-l Fermentor {#sec3.5}
--------------------------------------------------

[Figure 5(a)](#fig5){ref-type="fig"} shows the batch profile of DCW and CoQ10 production with the mutant PK38 in the 5-l fermentor under the optimal carbon and nitrogen sources. During the batch fermentation of PK38, cell aggregation was observed after incubation, and after 42 h, the cells were not grown further. The final yield of CoQ10 reached 43.94 mg/L, which was significantly higher than that reached in the flask culture (20.62 mg/L), indicating that the low constant agitation (300 rpm) provided in the 5-l fermentor might have enhanced cell-substrate contact \[[@B32]\], leading to the increase in CoQ10 productivity. The final biomass of PK reached 13.75 g/L, which was almost 2 times that obtained in the flask culture (7.86 g/mL). This indicates that the specific CoQ10 content was 3.196 mg/g-DCW, which is much higher than that achieved in the flask culture (2.624 mg/g-DCW).

As shown in the batch fermentation, CoQ10 production is mainly dependent on cell growth. A fed-batch fermentation of PK38 was carried out to get a high cell density and to increase more CoQ10 accumulation. When the residual sugar concentration of the broth dropped to about 17.5 g/L, 100 l of a sucrose solution (30%) was fed to the 5 l fermentor. As [Figure 5(b)](#fig5){ref-type="fig"} shows, sucrose feed was performed at 18, 30, and 40 h, respectively. The feed strategy was designed so the residual sugar was kept at a concentration of 17--28 g/L. The feeding profile was found to be optimum, by maintaining a higher concentration of the residual sugar in the broth during the log phase of PK38. As a result, the cell density increased to 25.99 g/L, which was almost twice the amount obtained in the batch fermentation. Specifically, the final CoQ10 production reached 92.87 mg/L in 96 h of incubation, which was significantly higher than the batch operation. This demonstrates that the specific CoQ10 content achieved 3.575 mg/g-DCW, which is much higher than that achieved in the batch fermentation.

In general, microorganisms will grow exponentially under the optimal condition. If the feed rate of the substrate is increased in proportion to the exponential growth rate, it is possible to maintain a high rate of cell growth for a long time \[[@B33]\]. Also, exponential feeding can limit the negative effect on the cell growth exerted by the sudden increase of sucrose. [Figure 5(c)](#fig5){ref-type="fig"} shows the profiles of DCW and CoQ10 production with the mutant PK38 in the 5-l fermentor under the exponential feeding fed-batch control. The sucrose feed started from 12 h when the residual sugar concentration in the broth dropped to 21 g/L. The sucrose solution (30%) flow rate profile was established in the equation described by Martínez et al. \[[@B34]\]. CoQ10 production increased quickly after 18 h of incubation, and the final yield reached 120.01 mg/L. The production of CoQ10 was proportional to cell growth, and the final biomass obtained was 31.09 g/L. Also, the exponential feeding fed-batch culture resulted in the highest specific CoQ10 content within the cell biomass, reaching 3.860 mg/g, superior to that of the aforementioned two cultures.

4. Conclusion {#sec4}
=============

This work demonstrates that the use of HHP could be a promising approach for mutagenesis to a CoQ10 producer *A. tumefaciens* strain. A mutant strain PK38 was obtained by HHP treatment: the intracellular CoQ10 content of this strain increased by 52.83% when compared to the wild-type strain. Even though the mechanism of HHP-induced mutagenesis is not clear, HHP treatment might affect the three enzymatic steps of CoQ10 biosynthesis. Sucrose was the best carbon source, and CSP and ammonium sulfate were the optimal nitrogen sources for CoQ10 production with PK38. Fed-batch culture could significantly improve cell growth and CoQ10 production. By the exponential feeding strategy, the cell biomass and CoQ10 production increased 126.11 and 173.12%, much higher than those obtained in the batch culture. There may be opportunities for further enhancement of the CoQ10 production in this species.
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![Death curve of *A. tumefaciens* caused by HHP treatment. Process temperature 25°C. log⁡⁡RF = log⁡⁡(*N*~0~/*N*). Data are shown as mean ± SD (*n* = 3).](JBB2012-607329.001){#fig1}

![Genealogy of mutant strains derived from *AT*1.2554. Mutation markers: NaN~3~^r^, sodium azide (NaN~3~) resistance; Tyr^−^, tyrosine auxotroph; Eth^r^, ethionine resistance; Dau^r^ daunomycin resistance; VK~3~^r^, vitamin K~3~ resistance. All the mutants were induced by HHP or UV + DES treatment. The specific CoQ10 content (mg/g dry cell weight) was obtained in flask tests.](JBB2012-607329.002){#fig2}

![Effect of various carbon sources on the cell growth and CoQ10 production. Cells were cultivated in the test tube at 28°C for 72 h. The carbon sources included glucose (1), fructose (2), lactose (3), maltose (4), sucrose (5), and xylose (6). Data are shown as mean ± SD (*n* = 3). Means with the same letter are not significantly different (*P* \< 0.05).](JBB2012-607329.003){#fig3}

![Effect of various nitrogen sources on the cell growth and CoQ10 production. Cells were cultivated in the test tube at 28°C for 72 h. The nitrogen sources included yeast extract (1), peptone (2), tryptone (3), soytone (4), ammonium sulfate (5), and CSP (6). Data are shown as mean ± SD (*n* = 3). Means with the same letter are not significantly different (*P* \< 0.05).](JBB2012-607329.004){#fig4}

![Profiles of DCW and CoQ10 production in batch (a), fed-batch (b), and exponential fed-batch (c) culture with PK38 in the 5-L fermentor at 28°C; residual sugar (RS, *filled square*), CoQ10 (*filled circle*), DCW (*filled inverted triangle*).](JBB2012-607329.005){#fig5}

###### 

HHP treatments on mutation of *A. tumefaciens*.

  Mutation         No. of strains  (*N*)   Positive mutant  (*r*  %)   Specific CoQ10 content  (mg/g DCW)   Improvement  (*r*  %)
  ---------------- ----------------------- --------------------------- ------------------------------------ -----------------------
  400 Mpa/10 min   56                      5                           1.645                                8.4
  250 Mpa/20 min   80                      10                          1.690                                11.3
  200 Mpa/30 min   78                      16                          1.784                                17.5

###### 

The experiment testing genetic stability and specific CoQ10 content of PK38.

  Generations                     2       4       6       8       10
  ------------------------------- ------- ------- ------- ------- -------
  Genetic markers^a^              \+      \+      \+      \+      \+
  Specific CoQ10 content (mg/g)   2.321   2.320   2.318   2.319   2.318

^a^Genetic markers included NaN~3~^r^, Tyr^−^, Eth^r^, and Vk~3~^r^.

###### 

Effect of sucrose on DCW and CoQ10 production by PK38 with batch culture.

  Sucrose (g/L)   DCW (g/L)         CoQ10 concentration (mg/L)   Specific CoQ10 content (mg/g DCW)
  --------------- ----------------- ---------------------------- -----------------------------------
  10              4.11 + 0.065^d^   9.55 + 0.196^d^              2.325 + 0.037^a^
  20              5.28 + 0.157^b^   12.27 + 0.110^b^             2.322 + 0.029^a^
  30              6.40 + 0.161^a^   14.88 + 0.172^a^             2.326 + 0.069^a^
  40              4.90 + 0.181^c^   11.40 + 0.284^c^             2.324 + 0.101^a^
  50              4.12 + 0.148^d^   9.56 + 0.056^d^              2.320 + 0.019^a^

Data are shown as mean ± SD (*n* = 3). Means with the same letter are not significantly different as indicated by Duncan\'s multiple range test (*P*\< 0.05).

###### 

Effect of CSP on DCW and CoQ10 production by PK38 with batch culture.

  CSP (g/L)   DCW (g/L)         CoQ10 production (mg/L)   Specific CoQ10 content (mg/g-DCW)
  ----------- ----------------- ------------------------- -----------------------------------
  10          6.67 + 0.061^c^   15.67 + 0.080^d^          2.351 + 0.016^c^
  20          7.16 + 0.116^b^   17.65 + 0.120^b^          2.466 + 0.017^b^
  30          7.46 + 0.095^a^   18.92 + 0.146^a^          2.536 + 0.047^a^
  40          7.07 + 0.080^b^   16.60 + 0.062^c^          2.347 + 0.035^c^
  50          7.62 + 0.038^a^   16.81 + 0.182^c^          2.207 + 0.022^d^

Data are shown as mean ± SD (*n* = 3). Means with the same letter are not significantly different as indicated by Duncan\'s multiple range test (*P*\< 0.05).

###### 

Effect of complex nitrogen sources on DCW and CoQ10 production by PK38 with batch culture.

  CSP + (NH~4~)~2~SO~4~ (g/L)   DCW (g/L)         CoQ10 production (mg/L)   Specific CoQ10 content (mg/g-DCW)
  ----------------------------- ----------------- ------------------------- -----------------------------------
  20 + 0                        7.16 + 0.116^d^   17.65 + 0.098^d^          2.466 + 0.017^c^
  20 + 5                        6.73 + 0.139^f^   16.17 + 0.091^f^          2.403 + 0.010^c^
  20 + 10                       6.92 + 0.097^e^   17.08 + 0.082^e^          2.467 + 0.027^c^
  20 + 15                       7.13 + 0.067^d^   17.60 + 0.115^d^          2.469 + 0.031^c^
  30 + 0                        7.46 + 0.095^c^   18.92 + 0.146^c^          2.536 + 0.047^b^
  30 + 5                        7.65 + 0.107^b^   19.40 + 0.284^b^          2.537 + 0.068^b^
  30 + 10                       7.86 + 0.090^a^   20.62 + 0.121^a^          2.624 + 0.032^a^
  30 + 15                       7.60 + 0.512^b^   18.54 + 0.085^c^          2.439 + 0.162^c^

Data are shown as mean ± SD (*n* = 3). Means with the same letter are not significantly different as indicated by Duncan\'s multiple range test (*P*\< 0.05).
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